Skip to content
How do laboratories interpret unexpected APTT prolongation?
8th ECAT International Symposium 2012
Speaker
Titel
Abstract
Presentation
E. Ajzner
How do laboratories interpret unexpected APTT prolongation?
Related items
Analytical Information :
8
Minimum citrate tube fill volume for routine coagulation testing
The use of quality indicators for the pre-analytical phase
Critical pre-examination variables in hemostasis testing
Defining analytical performance specifications: Consensus Statement from the 1st Strategic Conference of the European Federation of Clinical Chemistry and Laboratory Medicine
Comparison of two statistical software programs for determining reference intervals of screening coagulation assays
Assuring quality in the postanalytical phase
Analytical performance specifications for hemostasis parameters
The effect of Rivaroxaban on haemostasis assays; results from ECAT surveys
Cases :
4
Prekallikrein deficiency
Effect of high haematocrit levels on coagulation testing
A patient with mild haemophilia A
Lupus Anticoagulant-Hypoprothrombinemia Syndrome
ECAT Documents :
34
Phospholipids
Intrinsic Pathway of Coagulation
Hemostasis
Contact Activation
Common Pathway of Coagulation
Coagulation Cascade
Coagulation (Clotting)
Anticoagulant
Activated Partial Thromboplastin Time Test (APTT)
Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM)
Subcommittee on Plasma Coagulation Inhibitors. Recommendations for clinical laboratory testing for antithrombin deficiency; Communication from the SSC of the ISTH.
The results of the workshop on inhibitor testing
Test and equipment evaluation, a practical approach
External quality control: a new decade
Lupus Anticoagulant: Remarkable observations in ECAT surveys
Algoritm for Laboratory Investigations in Case of a prolonged APTT
Reference Intervals: Practical Approaches
Measurement of new oral anticoagulans
Factor VIII inhibitor testing – a way to comparable test results
Pre-analytical Variables in the Hemostasis Laboratory
Quality assurance of the entire diagnostic process
Establishing reference values - with low number of control samples
Slope and parallelism of APTT dilution curves: new insights
Auditing the pre-analytical phase: lessons from 40+ audits across Europe
The relevance of pre-operative hemostasis screening
The use of Guidelines in Haemostasis Laboratory Testing
Current practice in the pre-analitycal phase
Have international standards in haemostasis improved comparability of laboratory results?
Developmental haemostasis: consequences for clinical practice
Autovalidation of coagulation test results
EFLM/EQALM on the laboratory diagnosis of a prolonged APTT
What information does the doctor expect from the laboratory? What kind of services can a laboratory deliver to the physician?
When Haemostasis Assays Mislead
Systematic review and meta-analysis of within-subject and between-subject biological variation data of coagulation and fibrinolytic measurands
Guidelines :
7
ICSH recommendations for the performance and interpretation of activated partial thromboplastin time and prothrombin time mixing tests
Field Study Evaluating Optimal Interpretation Methods for Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies (ICSH)
ICSH Recommendations for Laboratory Measurement of Direct Oral Anticoagulants
ICSH Recommendations for laboratory measurement of ADAMTS13
ICSH Recommendations for Hemostasis Critical Values, Tests, and Reporting
Recommendations for collection of blood samples for coagulation testing, ICSH recommendations
Recommendations for processing of blood samples for coagulation testing, ICSH recommendations
Quality Issues :
3
Biological Variation of Hemostasis Variables in Thrombosis and Bleeding: Consequences for Performance Specifications
Does quality matter?
Bayesian strategy in long-term IQC results management: practical interest and compliance with standards
Surveys and Studies :
4
Pre- and Post-analytical Survey 2023
Pre- and Post-analytical Survey 2022
Pre- and Post-analytical Survey 2021
Emicizumab pilot study, part II
Questions or suggestions?
Clotpedia Support Form
Submit
Success